Overview
The ODAC Virtual Pre-Conference Symposium returns this November with an all-new lineup of compelling cases and expert voices in medical dermatology. Designed for clinicians who thrive on solving diagnostic puzzles and learning through real-world scenarios, this interactive, case-based event is your gateway to the ODAC experience.
Join moderator and ODAC Co-Chair Dr. Adam Friedman, and a distinguished panel of expert faculty, as they navigate some of the most pressing cases in contemporary dermatologic practice. Grab your favorite snack and settle in for an engaging evening of clinical insights, practical pearls, and forward-thinking discussion.
This year’s symposium will cover:
- Hyperhidrosis: Strategies and new tools to improve patient quality of life, led by Dr. Angela J. Lamb
- Chronic Itch: Expert approaches to tackling persistent pruritus, with Dr. Diego Ruiz Dasilva
- Hidradenitis Suppurativa: Lessons drawn from two patient journeys, presented by Dr. Leonardo Tjahjono
- Pediatric Alopecia Areata: Evidence-based management in children, directed by Dr. Leslie Castelo-Soccio
Each session will feature a lively panel discussion and audience Q&A, offering practical takeaways you can apply immediately in clinic.
Whether you’re looking to expand your clinical toolkit or stay at the forefront of medical dermatology, this symposium will challenge your thinking and elevate your patient care.
Mark your calendar and join us for an evening of discovery, dialogue, and dermatology’s most engaging cases—only at ODAC 2025!
Chair
Adam Friedman, MD, FAAD
Professor and Chair Residency Program Director Director of Translational Research Director of Supportive Oncodermatology Director of the Hidradenitis Suppurativa Clinic Department of Dermatology The George Washington University School of Medicine and Health Sciences Washington, District of Columbia
Faculty
Angela J. Lamb, MD, FAAD
Diego Ruiz Dasilva, MD, FAAD
Leonardo Tjahjono, MD, FAAD
Leslie Castelo-Soccio, MD, PhD, FAAD
Agenda
Please note all sessions listed in Eastern Time. Agenda and credit amount subject to change.
Tuesday, November 11
6:00 pm — 7:00 pm
Session I – Challenging Medical Dermatology Cases: A Case-Based Conversation With the Experts, Part 1
Session Introduction
Adam Friedman, MD
It’s Not Just Sweat! Harnessing All Tools to Improve Patient Quality of Life in Hyperhidrosis
Angela J. Lamb, MD, FAAD
Can’t Stop, Won’t Stop: Taking Down Chronic Itch
Diego Ruiz Dasilva, MD, FAAD
Panel Discussion and Audience Q&A
Adam Friedman, MD, FAAD
Diego Ruiz Dasilva, MD, FAAD
Angela J. Lamb, MD, FAAD
Tuesday, November 11
7:00 pm — 8:00 pm
Non-CME/CE Bonus Presentation
Speaker: Adam Friedman, MD, FAAD
Sponsored by Arcutis
Tuesday, November 11
8:00 pm — 9:00 pm
Session II: Challenging Medical Dermatology Cases: A Case-Based Conversation With the Experts, Part 2
Session Introduction
Adam Friedman, MD, FAAD
Hidradenitis Suppurativa Uncovered: Lessons From Two Clinical Journeys
Leonardo Tjahjono, MD, FAAD
The Hairless Truth: Treating Pediatric Patients With Alopecia Areata
Leslie Castelo-Soccio, MD, PhD, FAAD
Panel Discussion and Audience Q&A
Adam Friedman, MD, FAAD
Leslie Castelo-Soccio, MD, PhD, FAAD
Leonardo Tjahjono, MD, FAAD
Accreditation
TARGET AUDIENCE
The intended audience for this live activity includes dermatologists, dermatology residents, fellows and young practitioners, dermatology nurse practitioners and physician assistants, and other healthcare providers with an interest in treating patients with cutaneous diseases and disorders in persons of all ages and skin types.
LEARNING OBJECTIVES
After completing this activity, the participant should be better able to: [LIST][ITEM]Describe the pathophysiology, clinical presentation, and quality-of-life impact of hyperhidrosis, chronic pruritus, hidradenitis suppurativa, and pediatric alopecia areata to support accurate diagnosis and treatment. [ITEM]Evaluate and compare current and emerging pharmacologic and non-pharmacologic treatment modalities for each condition, with a focus on individualized, multidisciplinary approaches that maximize patient quality of life. [ITEM]Outline best practices and emerging research trends to holistically manage hyperhidrosis, chronic pruritus, hidradenitis suppurativa, and pediatric alopecia areata.
ACCREDITATION STATEMENTS
[JALOGOGAME] In support of improving patient care, Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
[underline][bold]Credit Designation[/bold][/underline]
[underline][bold]Physician Continuing Medical Education [/bold][/underline]
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 [italic]AMA PRA Category 1 Credit(s)™[/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
[underline][bold]Continuing Nursing Education [/bold][/underline]
The maximum number of hours awarded for this Continuing Nursing Education activity is 2.0 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.
Continuing Physician Assistant Education
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
*Agenda and Credit amount subject to change
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.